Principal Investigator: Dr. J. Chin
Urology Clinical Trials: 519.685.8500 ext. 58448
Hospital: London Health Sciences Centre - Victoria Hospital
Bladder Cancer - Recurrent
A Phase 3, Randomized, Active-Controlled, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of EN3348 (MCC) as Compared with Mitomycin C in the Intravesical Treatment of Subjects with BCG Recurrent or Refractory Non-Muscle Invasive Bladder Cancer
